혈관성형술용 풍선 시장 규모는 2024년에 20억 5,000만 달러로 평가되었으며, 2024년부터 2031년까지 CAGR 3.43%로 성장하여 2031년에는 26억 2,000만 달러에 달할 것으로 예측됩니다.
혈관성형술용 풍선은 혈관성형술에 사용되는 특수 의료기기입니다. 혈관성형술은 제한되거나 막힌 혈관(특히 동맥)을 열어 혈류를 촉진하는 기술입니다. 혈관성형술용 풍선의 가장 대표적인 용도는 심장에 혈액을 공급하는 동맥이 지방, 콜레스테롤, 기타 화학제품의 혼합물인 플라크(plaque)의 축적에 의해 수축되어 발생하는 관상동맥 질환의 치료입니다.
혈관성형술용 풍선은 심장에 혈액을 공급하는 동맥이 수축하거나 막혀서 발생하는 관상동맥질환 치료에 사용되는 중요한 의료기기입니다. 혈관성형술용 풍선의 가장 일반적인 용도는 경피적 관상동맥 성형술(PTCA)입니다. 이 치료는 관상동맥 협착 부위에 풍선이 달린 카테터를 삽입하는 시술입니다.
혈관성형술용 풍선은 의료기술의 발전과 심혈관 치료에서 환자의 치료성적 향상에 대한 중요성이 강조됨에 따라 향후 사용방법이 크게 변화할 것으로 예상됩니다. 경피적 관상동맥 성형술(PCI) 시 막히거나 제한된 혈관의 막힘을 제거하기 위해 사용되는 혈관성형술용 풍선은 점점 더 복잡해지고 개별 환자의 필요에 맞게 조정되고 있습니다.
세계의 혈관성형술용 풍선 시장을 형성하는 주요 시장 역학은 다음과 같습니다:
주요 시장 촉진요인
심혈관질환 이환율 증가 : 혈관성형술용 풍선 시장의 가장 중요한 촉진요인 중 하나는 전 세계적으로 심혈관질환(CVD)의 증가입니다. 관상동맥질환, 심장마비, 죽상동맥경화증은 식생활의 변화, 좌식생활, 고령화 등으로 인해 증가 추세에 있습니다.
최소침습수술로의 전환 : 의료계에서는 최소침습수술에 대한 수요가 증가하고 있으며, 혈관성형술은 이러한 추세에 부합하는 중요한 치료법 중 하나입니다. 최소침습수술이 선호되는 이유는 표준 개흉수술에 비해 회복시간이 짧고, 통증이 적으며, 문제 발생 위험이 낮기 때문입니다. 혈관성형술은 풍선이 달린 카테터를 막힌 부위까지 혈관에 삽입하는 것으로, 침습성이 적은 수술이며 국소 마취로 시행하는 경우가 많습니다.
풍선 디자인의 기술적 진보 : 혈관성형술용 풍선의 디자인과 기능의 지속적인 개선도 중요한 시장 촉진요인입니다. 동맥이 다시 수축하는 것을 방지하는 약물을 공급하는 약물 코팅 풍선으로 인해 혈관성형술의 성과가 크게 향상되었습니다. 또한, 난이도가 높은 병변이나 석회화 병변에 대응하는 특수 풍선 등의 개발로 혈관성형술의 혜택을 받을 수 있는 환자 수가 증가하고 있습니다.
주요 과제
풍선 파열의 위험 : 혈관성형술용 풍선의 가장 큰 문제 중 하나는 치료 중 풍선이 파열될 가능성입니다. 이는 풍선이 의도한 압력 한계를 초과하여 팽창하거나 매우 단단한 동맥 플라크 또는 석회화된 동맥 플라크와 접촉할 때 발생할 수 있습니다. 파열은 동맥 손상, 추가 치료의 필요성, 심장마비 위험 등의 결과를 초래할 수 있습니다.
복잡한 병변 탐색의 어려움 : 혈관성형술 풍선은 막힘의 원인에 도달하기 위해 관상동맥 내로 이동해야 합니다. 복잡한 병변, 예를 들어 곡선형 병변, 석회화가 진행된 병변, 굴곡진 병변 등은 큰 장애가 됩니다. 이러한 상황에서는 풍선이 통과하는 데 어려움을 겪거나 균일하게 팽창하지 않아 치료가 불충분하거나 효율이 떨어집니다.
재협착 및 폐색 재발 : 혈관성형술 후, 치료한 동맥이 다시 막힐 위험이 있습니다. 이는 흉터 조직이 형성되거나 치료 부위에 플라크가 재성장하기 때문일 수 있습니다. 재협착은 흔한 문제이며, 반복적인 치료나 스텐트삽입술과 같은 추가 치료가 필요합니다.
주요 동향
기술 향상 : 혈관성형술용 풍선 산업은 놀라운 기술 발전을 이룩하여 고도로 전문화되고 효과적인 장치를 생산하고 있습니다. 약물 코팅 풍선(DCB)이나 성능 향상을 위해 설계된 최첨단 소재는 기술 혁신의 한 예입니다. 약물 코팅 풍선은 치료 중 동맥벽에 직접 약물을 주입하여 치료 후 동맥의 재협착인 재협착을 방지하는 것을 목적으로 합니다. 이 기술은 혈관성형술 후 환자의 장기적인 예후를 개선합니다.
심혈관질환의 증가 : 심혈관질환(CVDs)의 빈도가 증가함에 따라 혈관성형술용 풍선에 대한 수요가 증가하고 있습니다. 관상동맥질환, 말초동맥질환 등 CVD는 식습관 장애, 운동 부족, 비만율 증가 등 생활습관 요인으로 인해 점점 더 널리 퍼지고 있습니다.
덜 침습적인 시술에 대한 관심 : 의료계에서는 보다 덜 침습적인 시술에 대한 수요가 증가하고 있으며, 혈관성형술용 풍선은 이러한 추세에 부합하는 제품입니다. 최소침습수술은 표준 수술법에 비해 회복시간 단축, 합병증 가능성 감소, 수술 후 통증 감소 등 다양한 장점이 있습니다.
Angioplasty Balloons Market size was valued at USD 2.05 Billion in 2024 and is projected to reach USD 2.62 Billion by 2031, growing at a CAGR of 3.43% from 2024 to 2031.
Angioplasty balloons are specialized medical devices used in angioplasty, a technique that opens restricted or clogged blood vessels, particularly arteries, to enhance blood flow. The most typical application for angioplasty balloons is to treat coronary artery disease which occurs when the arteries that deliver blood to the heart constrict owing to plaque buildup a mixture of fat, cholesterol, and other chemicals.
Angioplasty balloons are critical medical equipment used to treat coronary artery disease which develops when the blood arteries that feed blood to the heart constrict or get blocked. The most prevalent application for angioplasty balloons is percutaneous transluminal coronary angioplasty (PTCA). This treatment involves inserting a balloon-tipped catheter into a constricted portion of the coronary artery.
The future usage of angioplasty balloons is expected to change dramatically driven by advances in medical technology and a rising emphasis on improving patient outcomes in cardiovascular treatment. Angioplasty balloons which are used to unblock blocked or restricted blood arteries during percutaneous coronary interventions (PCI) are becoming more complex and adapted to individual patient needs.
The key market dynamics that are shaping the global angioplasty balloons market include:
Key Market Drivers:
Rising Cardiovascular Disease Incidence: One of the most important drivers of the angioplasty balloons market is the global increase in cardiovascular illnesses (CVDs). Coronary artery disease, heart attacks, and atherosclerosis are on the rise as a result of poor diets, sedentary lifestyles, and an aging population.
Shift towards Minimally Invasive Procedures: In the medical world, there is an increasing demand for minimally invasive procedures, and angioplasty is one of the important treatments that fits this trend. Minimally invasive operations are preferred because they often have shorter recovery times, less pain, and a lower risk of problems than standard open-heart surgeries. Angioplasty which includes threading a balloon-tipped catheter through the blood vessels to the site of the blockage is a less invasive procedure that may often be done under local anesthesia.
Technological Advancements in Balloon Design: Constant improvements in the design and functionality of angioplasty balloons are another important market driver. Drug-coated balloons which deliver medication to assist prevent arteries from constricting again have considerably improved angioplasty outcomes. Furthermore, the development of specialty balloons such as those intended for use in difficult or calcified lesions has increased the number of patients who can benefit from angioplasty.
Key Challenges:
Risk of Balloon Rupture: One of the biggest issues with angioplasty balloons is the possibility of balloon rupture during the treatment. This can happen if the balloon is inflated above its intended pressure limit or if it comes into contact with a very hard or calcified artery plaque. A rupture can result in consequences such as arterial damage, the necessity for additional treatments, and even the danger of a heart attack.
Difficulty Navigating Complex Lesions: Angioplasty balloons must travel through the coronary arteries to reach the source of the obstruction. Complex lesions such as those with substantial curvature, extensive calcification, or tortuous paths might present significant obstacles. In such circumstances, the balloon may struggle to move through or may not inflate evenly resulting in inadequate or inefficient treatment.
Restenosis and Recurrent Blockages: Following an angioplasty operation, there is a danger that the treated artery will become blocked again. This could be due to the creation of scar tissue or the regrowth of plaque at the treatment location. Restenosis is a common problem that requires repeat treatments or extra interventions like stenting.
Key Trends:
Technological Improvements: The angioplasty balloon industry is experiencing tremendous technological improvements, resulting in the creation of highly specialized and effective devices. Drug-coated balloons (DCBs) and cutting-edge materials designed to improve performance are examples of innovations. Drug-coated balloons are intended to deliver medication directly to the artery walls during the process, preventing restenosis, which is the re-narrowing of the artery following therapy. This technology improves patients' long-term results after angioplasty.
Rise in Cardiovascular Illnesses: The increasing frequency of cardiovascular illnesses (CVDs) is driving up demand for angioplasty balloons. CVDs including coronary artery disease and peripheral artery disease are becoming increasingly prevalent as a result of lifestyle factors such as poor food, lack of exercise, and rising obesity rates.
Focus on Less Invasive Procedures: In the medical world, there is a rising demand for less invasive procedures, and angioplasty balloons fit right in with this trend. Minimally invasive procedures provide various advantages over standard surgical methods including quicker recovery times, a lower chance of complications, and less post-operative pain.
Here is a more detailed regional analysis of the global angioplasty balloons market:
North America:
The high prevalence of cardiovascular disease and an aging population are the primary drivers of the North American angioplasty balloons market. The United States leads the regional market due to its advanced healthcare infrastructure and high healthcare spending. The rising incidence of coronary artery disease (CAD) and peripheral artery disease (PAD), the growing use of less invasive procedures, and technological developments in balloon catheter design are all major drivers of the North American angioplasty balloons market.
According to the Centers for Disease Control and Prevention (CDC), heart disease is still the top cause of death in the United States accounting for approximately one out of every four deaths. In 2020, around 697,000 persons in the United States died of heart disease. According to the American Heart Association, coronary heart disease alone accounted for 382,820 deaths in 2020. These statistics highlight the region's significant cardiovascular disease burden which drives demand for angioplasty procedures and, as a result, angioplasty balloons. Another important aspect driving market expansion is the aging population in North America.
Asia Pacific:
The Asia Pacific angioplasty balloons market is expanding rapidly, with China emerging as the fastest-growing market due to its large population and rising frequency of cardiovascular illnesses. This trend is projected to continue in the next years driven by several major variables. The increased incidence of cardiovascular disorders, notably coronary artery disease (CAD) is the key driving force behind the Asia Pacific angioplasty balloons market. According to the World Health Organization (WHO), cardiovascular illnesses account for 31% of all fatalities worldwide with a large proportion occurring in low- and middle-income nations many of which are located in the Asia Pacific region.
Another key driver is the improvement of healthcare infrastructure and increased healthcare spending in several Asia Pacific countries. For example, the Australian Institute of Health and Welfare stated that healthcare spending in Australia reached AUD 185.4 billion in 2017-18, up 3.9% from the year before. In Japan, the Ministry of Health, Labour, and Welfare stated that national medical care expenditure totaled JPY 43.4 trillion in fiscal year 2018, up 0.8% over the previous year. The increased usage of minimally invasive procedures such as angioplasty is also driving market expansion. The Indian Council of Medical Research (ICMR) reported a considerable increase in the number of cardiac catheterization facilities across India allowing for more angioplasty treatments.
The Global Angioplasty Balloons Market is segmented based on Product Type, Application, Packaging Type, and Geography.
Normal Ballons
Cutting Ballons
Drug-Eluting Balloons
Based on the Product Type, the Global Angioplasty Balloons Market is bifurcated into Normal Ballons, Cutting Ballons, and Drug-Eluting Balloons. The drug-eluting balloons (DEBs) segment is expected to dominate the angioplasty balloons market. DEBs are favored due to their ability to deliver anti-proliferative drugs directly to the arterial wall reducing the risk of restenosis (re-narrowing of the artery) after the procedure. This feature is particularly crucial in complex cases where restenosis is a common concern. The growing preference for minimally invasive treatments and improved patient outcomes further drives the demand for DEBs making them the dominant product type in the market.
Coronary Angioplasty
Peripheral Angioplasty
Based on the Application, the Global Angioplasty Balloons Market is bifurcated into Coronary Angioplasty and Peripheral Angioplasty. The coronary angioplasty segment is dominant in the global angioplasty balloons market primarily due to the high prevalence of cardiovascular diseases (CVDs) such as coronary artery disease (CAD). Coronary angioplasty, a procedure to open blocked or narrowed coronary arteries is widely used to restore blood flow to the heart making it a critical treatment for patients with CAD.
Hospitals
Ambulatory Surgical Centers
Catheterization Laboratories
Based on the End-Users, the Global Angioplasty Balloons Market is bifurcated into Hospitals, Ambulatory Surgical Centers, and Catheterization Laboratories. In the global angioplasty balloons market, the hospital segment is dominant. Hospitals are the primary setting for angioplasty procedures due to their advanced infrastructure, availability of specialized medical personnel, and the ability to handle complex cases. Hospitals often have dedicated cardiac care units and catheterization laboratories making them the preferred choice for both emergency and elective angioplasty procedures. Additionally, hospitals typically manage a higher volume of patients including those with severe or complicated cardiovascular conditions that require immediate intervention, further driving the demand for angioplasty balloons.
North America
Europe
Asia Pacific
Rest of the World
Based on Geography, the Global Angioplasty Balloons Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. The North American region dominates the global angioplasty balloons market primarily due to its advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and widespread adoption of minimally invasive procedures. The presence of leading medical device companies and strong support for research and development further bolster the market. Additionally, North America benefits from favorable reimbursement policies and a well-established regulatory environment that facilitates the approval and use of angioplasty balloons.
The "Global Angioplasty Balloons Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Medtronic, Boston Scientific Corporation, Johnson & Johnson Services, Inc., Abbott, C. R. Bard, Inc., Spectranetics, Terumo Medical Corporation, Cardinal Health, BIOTRONIK, Cook, ENDOCOR GmbH, B. Braun Melsungen AG.